Clinical Trials Directory

Trials / Terminated

TerminatedNCT00047567

Open-label Adjunctive Zonisamide for Bipolar Disorder

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
20 (planned)
Sponsor
Elan Pharmaceuticals · Industry
Sex
All
Age
6 Years – 17 Years
Healthy volunteers
Not accepted

Summary

To study the safety and efficacy of zonisamide as adjunctive therapy for children and adolescents with bipolar I or II disorder.

Conditions

Interventions

TypeNameDescription
DRUGzonisamide

Timeline

Start date
2002-07-01
Completion
2002-07-01
First posted
2002-10-10
Last updated
2015-12-14

Source: ClinicalTrials.gov record NCT00047567. Inclusion in this directory is not an endorsement.

Open-label Adjunctive Zonisamide for Bipolar Disorder (NCT00047567) · Clinical Trials Directory